Stay updated on Sitravatinib Combo Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib Combo Clinical Trial page.
Latest updates to the Sitravatinib Combo Clinical Trial page
- Check5 days agoChange DetectedUpdated the Locations section to include multiple states (Colorado, Indiana, Massachusetts, Michigan, Minnesota, Nebraska, New York, Ohio, Texas, Virginia) and updated the page revision from v3.3.2 to v3.3.3.SummaryDifference1%
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedA minor revision label from v3.3.1 to v3.3.2 appears on the page, with no visible changes to the study details or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check34 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.1; no changes to the study content, eligibility criteria, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check41 days agoChange DetectedRemoved the government funding notice banner that warned about possible delays and provided status links. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check55 days agoChange DetectedThe new screenshot retains the same study details, with only minor textual edits and an updated last-updated timestamp. No changes to interventions, eligibility criteria, or primary outcomes.SummaryDifference0.4%
- Check70 days agoChange DetectedDifference0.1%
Stay in the know with updates to Sitravatinib Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo Clinical Trial page.